Alan Ezekowitz
InvestorVenture Partner at Third Rock Ventures · Board director at Septerna · Board director at Fulcrum Therapeutics
Princeton, New Jersey
Writes $100K – $5M checks · typically $1.5M
Find your path to Alan
262 people in our graph share verified history with Alan — schools, employers, funds. One of them is your warm intro.
About
A physician scientist who spent over 20 years at Harvard Medical School, heading the Laboratory of Developmental Immunology and MassGeneral Hospital for Children. He later led a franchise at Merck and co-founded Abide Therapeutics, acquired by Lundbeck in 2019.
Invests in
BiotechDeep TechHealthtech
Board director at Septerna
Intro paths
In turn, Alan can intro founders to Septerna's investors below.
Septerna's investors · 5
Co-founders at Septerna
Board director at Fulcrum Therapeutics
Intro paths
In turn, Alan can intro founders to Fulcrum Therapeutics's investors below.
Fulcrum Therapeutics's investors · 3
Experience
- Third Rock VenturesAdvisory Partnercurrent2023 — presentBoston MA USA
- Third Rock VenturesVenture Partner2019 — 2023Greater Boston
- Abide TherapeuticsPresident and CEO2011 — 2019
- Vividion Therapeutics. Inc.Senior Consultant2015 — 2016San Diego Metropolitan Area
- Alan Ezekowitz LLCPrincipal2011
- Merck Sharp & DohmeSVP and Franchise Head2006 — 2011
- Mass General HospitalChief MassGeneral Hospital for Children1999 — 2006Boston, Massachusetts, United States
- Chief, MassGeneral Hospital for Children and Head fo Laboratory for Developmental Immunology at MGH,Charles Wilder Professor of Pediatrics Harvard Medical School1995 — 2005Boston, Massachusetts, United States
Skills & more
+8 more
Clinical TrialsOncologyCross-functional Team LeadershipAsthmaInfectious DiseasesVaccinesBiopharmaceuticalsStrategic PlanningFrom Alan's professional profile.
Investments
Led
Abide Therapeutics
Investor
Sources: the firm's website · curated public sources.
Colleagues at Third Rock Ventures
Network10
Investors connected to Alan in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Alan Ezekowitz?
- A physician scientist who spent over 20 years at Harvard Medical School, heading the Laboratory of Developmental Immunology and MassGeneral Hospital for Children. He later led a franchise at Merck and co-founded Abide Therapeutics, acquired by Lundbeck in 2019.
- Where does Alan Ezekowitz work?
- Alan Ezekowitz is Venture Partner at Third Rock Ventures and Board director at Septerna and Board director at Fulcrum Therapeutics.
- What does Alan Ezekowitz invest in?
- Alan Ezekowitz invests in Biotech, Deep Tech, Healthtech.
- What check size does Alan Ezekowitz write?
- Alan Ezekowitz typically writes checks of $100K – $5M.
- What companies has Alan Ezekowitz invested in?
- Investments tracked here include Abide Therapeutics, Septerna.
- Where did Alan Ezekowitz go to school?
- Alan Ezekowitz studied at University of Oxford (DPhil, Cell/Cellular and Molecular Biology); University of Cape Town (Medicine).
- Does Alan Ezekowitz lead rounds?
- Yes — Alan Ezekowitz has led 1 tracked investment.
Same school
Also attended University of Oxford1,755
+ 1,749 more
Also attended University of Cape Town299
+ 293 more
Shared employers
Also worked at Third Rock Ventures90
+ 84 more
Also worked at Vividion Therapeutics. Inc.4
Also worked at Merck Sharp & Dohme261
+ 255 more





















































